{
  "docId": "019de075-3db6-70cc-be39-8d329d3330a5",
  "docSlug": "9a5a1cb2d23439a1f3fda2d5175b10b5",
  "documentTitle": "Alkermes | Results Presentation Deck | 17 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 17,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "kpi_overview",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 7,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-3db6-70cc-be39-8d329d3330a5/11",
  "deckHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5",
  "deckJsonHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5.json",
  "deckAnchorHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.5,
        "x": 0.05,
        "y": 0.235
      },
      "kind": "chart",
      "text": "LYBALVI Quarterly Net Sales ($M)",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3555084f-3176-4008-b0c8-74095f3abf86",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.87
      },
      "kind": "disclaimer",
      "text": "*These expectations were initially provided by the Company on Feb. 16, 2023. The Company reiterates these expectations as of July 26, 2023 and such expectations are effective only as of this date. The Company expressly disclaims any obligation to update or reaffirm these expectations.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4456798d-e558-42f6-a2ba-8c83c9f75995",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.35,
        "x": 0.6,
        "y": 0.3
      },
      "kind": "list",
      "text": "Q2'23 net sales of $47.0M reflect 24% sequential growth compared to Q1'23. Q2'23 gross-to-net deductions: ~26%, reflecting the Company’s commercial access strategy to limit rebates at this stage of launch. Outlook: FY'23 net sales expected to range from $180M – $205M*",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "45256f6c-1bca-421e-a1bc-7733939a6e65",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.05,
        "y": 0.12
      },
      "kind": "title",
      "text": "LYBALVI® Performance and Expectations",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b5bfcf91-2e84-469b-9645-97b0f22e05a1",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 13,
      "from": 4,
      "beatId": "d5f4e08a-d337-402e-8a2b-d07acbe069eb",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Key Performance Indicator Overview",
      "beatSlug": null,
      "evidence": "Slides 4-13 provide an overview of the company's financial results, revenue summary, and product performance.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 11,
      "from": 7,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "7aacdd12-f2ee-4912-b182-10d9fd1385f9",
      "evidence": "The presentation highlights the company's topline growth and diversification, implying that not achieving this growth would have negative consequences.",
      "position": 0,
      "objective": "What are the implications of not achieving topline growth and diversification?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 11,
      "from": 9,
      "name": "Voice Of Customer",
      "slug": "51-voice-of-customer",
      "bestFor": "Product strategy, customer experience, market research",
      "matchId": "d07d2911-1274-4deb-8262-177be0bf2ba5",
      "evidence": "Slides 9-11 provide an overview of LYBALVI prescription growth trends, implying that customer feedback and market data are driving the company's commercial strategies.",
      "position": 1,
      "objective": "What do customers think about LYBALVI prescription growth trends?",
      "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response",
      "confidence": 0.6,
      "description": "Let customer quotes and feedback drive the narrative and validate the insight"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}